Antibodies to intrinsic factor (IF) bind to IF and prevent formation of the IF-B 12 complex, further inhibiting vitamin B 12 absorption
BPC-157 Buy 1 Buy 2 Save 5% Buy 3 Save 10% Buy 4 Save 15% FOR LABORATORY USE ONLY This product is intended strictly for controlled research environments and must not be: Used in any human or clinical testing Administered to individuals under any circumstances Distributed for unauthorised investigational use Technical Specifications: Synonyms: BPC-157
However, human clinical trials specifically for disc herniations are limited, so definitive claims about disc healing in humans cannot yet be made
Because they attack tissue repair from completely different angles
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial
Vitamin B12. Advances in Food and Nutrition Research 83 (2018): 215279